Comments
Infinity halts drug trials, shares fall
19.06.2012. | (Reuters) - Infinity Pharmaceuticals stopped two mid-stage trials of its experimental drug to treat a rare bone marrow disorder and a type of bone cancer, sending its shares down as much as 21 percent....
